Skip to main content
MANIFOLD
What will the prevailing sentiment be about Rapamycin as a longevity drug in 2028?
11
Ṁ10kṀ1k
2028
9%
Wonder-drug: Most adults should consider it
20%
Valuable but imperfect: Some healthy adults should consider it, but there are major drawbacks
26%
Unproven but promising: Too early to tell
33%
Ineffective: Any benefits are too small to be worth the drawbacks
12%
Harmful/scandalous: Clear serious drawbacks that last beyond cessation of treatment

I'll post a proposed resolution here for discussion at least one week before resolving. May resolve to a mixture of up to two different choices in borderline cases.

If there's any substantial disagreement, I'll ask a popular LLM-style chatbot to select a resolution based on the title of the market, the choices, and the text of the ten first Google News results for "rapamycin for longevity".

Market context
Get
Ṁ1,000
to start trading!